Era Mandiri Cemerlang Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp90 (market cap 74.17B, 23.53M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 12.33M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 6.3× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (23.53M versus 12.33M). Which is the better fit depends on your goals.
| IKAN | PRDL | |
|---|---|---|
Market Cap | 74.17B | 470.58B |
Volume | 23.53M | 12.33M |
Lot | 235.31K | 123.26K |
Turnover | 2.14B | 3.24B |
Average Price | 90.8 | 263.24 |
Value | 2.14B | 3.24B |
Indicative Equilibrium Price | 89 | 272 |
Indicative Equilibrium Volume | 71.5K | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →